repaglinid stada 1 mg tablete
stada arzneimittel ag - repaglinid - tableta - repaglinid 1 mg / 1 tableta - repaglinid
repaglinid stada 0,5 mg tablete
stada arzneimittel ag - repaglinid - tableta - repaglinid 0,5 mg / 1 tableta - repaglinid
repaglinid stada 1 mg tablete
stada arzneimittel ag - repaglinid - tableta - repaglinid 1 mg / 1 tableta - repaglinid
repaglinid stada 2 mg tablete
stada arzneimittel ag - repaglinid - tableta - repaglinid 2 mg / 1 tableta - repaglinid
repaglinid stada 4 mg tablete
stada arzneimittel ag - repaglinid - tableta - repaglinid 4 mg / 1 tableta - repaglinid
repaglinid stada 4 mg tablete
stada arzneimittel ag - repaglinid - tableta - repaglinid 4 mg / 1 tableta - repaglinid
repaglinid stada 0,5 mg tablete
stada arzneimittel ag - repaglinid - tableta - repaglinid 0,5 mg / 1 tableta - repaglinid
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologi - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
esomeprazol stada 20 mg trde gastrorezistentne kapsule
stada arzneimittel ag - esomeprazol - gastrorezistentna kapsula, trda - esomeprazol 20 mg / 1 kapsula - esomeprazol
esomeprazol stada 40 mg trde gastrorezistentne kapsule
stada arzneimittel ag - esomeprazol - gastrorezistentna kapsula, trda - esomeprazol 40 mg / 1 kapsula - esomeprazol